GRIN-related Disorder
GRIN-related disorder is a rare neurodevelopmental condition caused by mutations in the GRIN genes, affecting brain function and development, often leading to intellectual disability, seizures, and other neurological symptoms.
We are studying a new medication to see if it is safe and helps reduce seizures and improve behavior in children with GRIN-related disorder. This trial aims to find the right dose and understand its effects over time.
Health conditions and diseases that the clinical trial is designed to study and treat.
GRIN-related disorder is a rare neurodevelopmental condition caused by mutations in the GRIN genes, affecting brain function and development, often leading to intellectual disability, seizures, and other neurological symptoms.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.